Ziprasidone for the treatment of generalized anxiety comorbidity in patients with bipolar disorder
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2014
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders; Generalised anxiety disorder
- Focus Therapeutic Use
- 15 Jan 2009 Status changed from recruiting to discontinued, as per ClinicalTrials.gov record.
- 22 Oct 2006 New trial record.